Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-01 @ 7:19 AM
Study NCT ID:
NCT06651593
Status:
RECRUITING
Last Update Posted:
2025-08-15
First Post:
2024-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumors | View |
Keywords: